Talaris Therapeutics financials at a glance
| Year | Year | 2021 | 2022 | 2023 | 2020 | |
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-16.40 | $-17.90 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 |
| Sha. | Shares |
|
41.35m | 5.21m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-39.99M | $-60.86M | $0.00M | $-19.21M |
| FCF | Free Cash Flow |
|
$-42.43M | $-77.00M | $0.00M | $-20.50M |
| FCFS | Free Cash Flow Per Share |
|
$-1.46 | $-15.49 | $0.00 | $-30.66 |